Skip to main content
pCPA File Number:
21066
Negotiation Status:
Concluded with an LOI
Indication(s):
Eosinophilic Asthma
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
SR0561-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: